Related Experiment Videos
Biotechnology in reproductive medicine
1Department of Gynaecology and Obstetrics, University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria. johanna.ulmer@uibk.ac.at
Differentiation; Research in Biological Diversity
|February 14, 2002
Summary
This review covers cloning progress in mammals for pharmaceutical, diagnostic, and therapeutic uses. It discusses risks and ethical debates surrounding reproductive cloning, especially in humans.
Area of Science:
- Biotechnology and Mammalian Cloning
- Medical Applications of Cloning
Background:
- Mammalian cloning advancements offer pharmaceutical and diagnostic potential.
- Molecular cloning techniques are integral to preimplantation genetic diagnosis (PGD).
Purpose of the Study:
- To review past and current progress in pharmaceutical, diagnostic, therapeutic, and reproductive cloning in mammals.
- To discuss applications and risks associated with cloning technologies.
Main Methods:
- Literature review of pharmaceutical, diagnostic, therapeutic, and reproductive cloning.
- Analysis of stem cell engineering and preimplantation genetic diagnosis (PGD).
Main Results:
- Transgenic farm animals can produce human gene products for medical use.
- PGD aids in detecting genetic abnormalities in early embryos.
- Stem cell engineering presents therapeutic but controversial applications.
- Reproductive cloning in mammals carries risks of developmental malformations.
Conclusions:
- Cloning technologies have diverse applications in medicine and diagnostics.
- Ethical considerations and risks, particularly for human reproductive cloning, require careful evaluation.
- Further research and global discussion are needed for human reproductive cloning.